Effect of Selective iNOS Inhibition During Human Endotoxemia

Status Completed

Clinical Trial Summary

Sepsis or endotoxemia is manifested by hypotension, resistance to vasopressors, myocardial depression,and altered organ blood flow distribution. The mechanisms underlying the cardiovascular dysfunction during sepsis are complex; however, they are partially mediated by an uncontrolled production of NO by inducible NO synthase (iNOS).Control subjects received 2 ng/kg E. coli endotoxin, whereas the active intervention group received endotoxin in the presence of selective iNOS-inhibitor aminoguanidine. Hemodynamics, vascular responses to norepinephrine, acetylcholine and sodium nitroprusside, as well as circulating cytokines and other mediators of inflammation were measured. We tested the hypothesis that inhibition of NO-synthesis prevented the LPS-mediated insensitivity to noradrenalin and endothelial-dependent vasorelaxation. Furthermore, we tested whether NO participates in occurrence of the endotoxin tolerance in humans by using the iNOS inhibitor aminoguanidine on healthy volunteers with endotoxemia. At 0; 2 and 4 hours after the LPS challenge whole blood was stimulated with five TLR agonists in vitro and pro- and anti-inflammatory cytokines were measured.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Pharmacokinetics/Dynamics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

Endotoxemia

Clinical Trial Details

NCT number	NCT00184990
Study type	Interventional
Source	Radboud University
Contact
Status	Completed
Phase	Phase 1
Start date	January 2005
Completion date	September 2005

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04117802` - Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome	N/A
Completed	`NCT02922673` - The Effects of Acetylsalicylic Acid on Immunoparalysis Following Human Endotoxemia	N/A
Completed	`NCT01766414` - In Vivo Effects of C1-esterase Inhibitor on the Innate Immune Response During Human Endotoxemia - VECTOR II	Phase 3
Completed	`NCT04130321` - Demonstration of the Prebiotic-like Effects of Camu-camu Consumption Against Obesity-related Disorders in Humans	N/A
Completed	`NCT02612480` - Ticagrelor in Human Endotoxemia Response to Human Endotoxemia	N/A
Completed	`NCT01474629` - Probiotic Sport Study	N/A
Completed	`NCT00246714` - Pathophysiology and Clinical Relevance of Endotoxin Tolerance in Humans	Phase 1
Recruiting	`NCT06147440` - Different Dietary Patterns	N/A
Recruiting	`NCT03901807` - Safety and Efficacy of Polymyxin B Hemoperfusion (PMX) for Endotoxemic Septic Shock in a Randomized, Open-Label Study	N/A
Completed	`NCT03754504` - Effects of Cranberry Powder Supplements on Gut Microbiota Diversity and Metabolic Syndrome	N/A
Completed	`NCT03800277` - Effect of Cranberry and Agaves Extract on Microbiota and Intestinal Health	N/A
Completed	`NCT00785018` - In Vivo Effects of C1-esterase Inhibitor on the Innate Immune Response During Human Endotoxemia	N/A
Recruiting	`NCT00413348` - Type 2 Diabetes and the Effect of Probiotics	N/A
Recruiting	`NCT00413465` - Study of Renal Blood Flow During Human Endotoxemia	N/A
Completed	`NCT00412906` - Study of Gene Activity in Fat and Muscle in Diabetics and Healthy Controls	N/A
Completed	`NCT05752968` - Elevated Levels of Antibodies to Endotoxin Core in Hemodialysis Patients With Peripheral Artery Disease
Completed	`NCT01374711` - The Effects of Immunostimulation With GM-CSF or IFN-y on Immunoparalysis Following Human Endotoxemia	N/A
Completed	`NCT00916448` - The Effects of Atazanavir-induced Hyperbilirubinemia During Human Endotoxemia	N/A
Completed	`NCT00332267` - Cerebral Blood Flow and Metabolism During Hypoxia and Endotoxemia	N/A
Completed	`NCT03482284` - Effect of Monosaccharides on Intestinal Barrier Function	N/A